MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galectin Therapeutics (GALT) Ownership - Who owns Galectin Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
171.26M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
82.52M
Revenue
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GALT
Capitalization
171M
P/E Ratio
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
82.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-73.31M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
61K
Current Ratio
2.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
32.2M
Shares Outstanding - Current
62.3M
Total Liabilities
97M
Total Volume MTD
N/A
Value
-1
Gain YTD
65.663
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com